Coming back to post #7, because the follow-up matters more than the original answer. Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want. Two people can read the same figure differently here and both be reasonable.
Splitting a vial for two laboratories: how to do it without ruining both — setting out what I have, and where I think it stops being reliable.
Something about splitting a vial does not reconcile and I would like a second pair of eyes before I decide which half is wrong.
Two sources, both reputable, giving figures that cannot both be right unless they are measuring different quantities. My suspicion is that they are, and I cannot see how.
Narrowing the opening post, because the general version has more than one answer.
I keep a log for splitting a vial specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and settled it.
The opening post put the caveat in the right place and I want to underline it.
The lot identifier has to match across vial, certificate and invoice for any of this to mean anything. It is the floor and it is worth checking every time.
Method has to travel with the number. A verification record without the method is not a record; it is a figure.
If anyone has run this properly I would rather read that than my own guess.
I read post #3 twice before replying, because I had assumed the opposite.
Practical note on splitting a vial: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would allow.
Post #3 answers the question as asked. The question underneath it is different.
The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible.
Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and selective reporting. The extra effort is worth it.
Written quickly, so the reasoning may be tighter than the wording.
A request rather than an answer: could whoever has the primary source for splitting a vial post it? I have seen the claim three times this month and each version had lost a qualifier.
Coming back to post #7, because the follow-up matters more than the original answer.
Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want.
Two people can read the same figure differently here and both be reasonable.
The four services answer different questions. A documentation review cannot tell you what is in a vial and a purity assay cannot tell you whether the records are internally consistent.
One of those cases where knowing the mechanism does not help the decision.
PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over time rather than at a point in time.
That is the practical version. The rigorous version is longer and says the same thing.
Practical experience of splitting a vial, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it interpretable.
Picking up post #12: that is the part I would want checked first.
Splitting a vial was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
On post #14 — agreed on the reasoning, with one qualification.
A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which.
Adding it in case it saves somebody the afternoon it cost me.
Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not establish a pattern.
I would not lead a decision with this, but I would not ignore it either.
Agreed, and I will stop repeating the version of this I had been repeating.
Where two services agree with each other and with the declared figure, that is a genuinely strong result and it applies to that lot.
Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies reproducibility but uses the same method.
Worth separating two things that post #19 runs together.
Combining a chromatographic result with a documentation review gives a more complete picture than two chromatographic results, because the failure modes are different.
That has held every time I have looked, which is not the same as always.
Sensible. I would want the same detail before I acted on it either.
Verification records are dated because they expire in usefulness. A result from two years ago describes a lot from two years ago.
Post #23 answers the question as asked. The question underneath it is different.
Distinguishing three things in the splitting a vial discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation that gets attached to both.
On post #23 — agreed on the reasoning, with one qualification.
Cross-checking one lot with two services independently is the cleanest test available and is rarely done because it costs twice as much.
That is the version I use. It may not be the version that is correct.
Picking up post #23: that is the part I would want checked first.
Where two services agree with each other and with the declared figure, that is a genuinely strong result and it applies to that lot.
That holds for the case as described. Change the assumptions and it may not.
Splitting a vial is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.